Study shows benefit of universal genetic testing after breast cancer diagnosis

byWalter and Eliza Hall Institute of Medical ResearchClassification of 31 participants found to carry pathogenic gene variants, by gene, estimated risk of having a pathogenic gene variant,* and

Updated on: January 29,2024

Study shows benefit of universal genetic testing after breast cancer diagnosis

byWalter and Eliza Hall Institute of Medical ResearchClassification of 31 participants found to carry pathogenic gene variants, by gene, estimated risk of having a pathogenic gene variant,* and

Updated on:January 29,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on: January 16,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on:January 16,2024

Maternal obesity may promote liver cancer

by University of GenevaCredit:JHEP Reports(2024). DOI: 10.1016/j.jhepr.2024.101056Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major p

Updated on: March 20,2024

Maternal obesity may promote liver cancer

by University of GenevaCredit:JHEP Reports(2024). DOI: 10.1016/j.jhepr.2024.101056Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major p

Updated on:March 20,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on: March 06,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on:March 06,2024

New insights into sarcoma open novel avenues of study

by Karolinska InstitutetCredit: CC0 Public DomainUndifferentiated uterine sarcoma is a very rare but extremely aggressive cancer type. It can be divided into four groups with different characteri

Updated on: March 06,2024

New insights into sarcoma open novel avenues of study

by Karolinska InstitutetCredit: CC0 Public DomainUndifferentiated uterine sarcoma is a very rare but extremely aggressive cancer type. It can be divided into four groups with different characteri

Updated on:March 06,2024

Vaccine boosts response of engineered T cells, may help eradicate solid tumors

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainEngineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. How

Updated on: January 30,2024

Vaccine boosts response of engineered T cells, may help eradicate solid tumors

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainEngineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. How

Updated on:January 30,2024

Sticky cell fingers help keep breast tumors contained

by University of TurkuBreast cancer cells break through the basement membrane acting as a biological barrier. In the image, the finger-like projections formed by the actin of cancer cells invadin

Updated on: February 24,2024

Sticky cell fingers help keep breast tumors contained

by University of TurkuBreast cancer cells break through the basement membrane acting as a biological barrier. In the image, the finger-like projections formed by the actin of cancer cells invadin

Updated on:February 24,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on: May 31,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on:May 31,2024

Genetically engineered bacteria can detect cancer cells in a world-first experiment

by Dan Worthley,The ConversationCredit: AI-generated imageAs medical technology advances, many diseases could be detected, prevented and cured with cells, rather than pills.This branch of medici

Updated on: February 18,2024

Genetically engineered bacteria can detect cancer cells in a world-first experiment

by Dan Worthley,The ConversationCredit: AI-generated imageAs medical technology advances, many diseases could be detected, prevented and cured with cells, rather than pills.This branch of medici

Updated on:February 18,2024

High fail rate for melanoma self-checks increasing cancer risk, new study finds

bySouthern Cross UniversityCredit: ROCKETMANN TEAM from PexelsAustralians are unable to recognize malignant melanomas on their own skin, calling into question the effectiveness of national self-

Updated on: July 05,2024

High fail rate for melanoma self-checks increasing cancer risk, new study finds

bySouthern Cross UniversityCredit: ROCKETMANN TEAM from PexelsAustralians are unable to recognize malignant melanomas on their own skin, calling into question the effectiveness of national self-

Updated on:July 05,2024

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Updated on: January 23,2024

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Updated on:January 23,2024

Salmonella exposure a risk for colon cancer, finds study

byUniversity of Illinois at ChicagoGraphical Abstract. Credit:Cell Reports Medicine(2022). DOI: 10.1016/j.xcrm.2022.100852A new study published in the journalCell Reports Medic

Updated on: January 23,2024

Salmonella exposure a risk for colon cancer, finds study

byUniversity of Illinois at ChicagoGraphical Abstract. Credit:Cell Reports Medicine(2022). DOI: 10.1016/j.xcrm.2022.100852A new study published in the journalCell Reports Medic

Updated on:January 23,2024